SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001161697-20-000376
Filing Date
2020-08-24
Accepted
2020-08-24 17:01:24
Documents
3
Period of Report
2020-08-23
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K CURRENT REPORT FOR 08-23-2020 form_8-k.htm 8-K 11556
2 PRESS RELEASE DATED AUGUST 24, 2020 ex_99-1.htm EX-99 5523
3 GRAPHIC angiosoma_logo.jpg GRAPHIC 10351
  Complete submission text file 0001161697-20-000376.txt   32680
Mailing Address 2500 WILCREST DRIVE, 3RD FLOOR HOUSTON TX 77042
Business Address 2500 WILCREST DRIVE, 3RD FLOOR HOUSTON TX 77042 832-781-8521
AngioSoma, Inc. (Filer) CIK: 0001502152 (see all company filings)

IRS No.: 273480481 | State of Incorp.: NV | Fiscal Year End: 0930
Type: 8-K | Act: 34 | File No.: 000-55072 | Film No.: 201128541
SIC: 2834 Pharmaceutical Preparations